Christiane S.
- Country
- France
- Department
- Hépato-gastro-entérologie
Research Overview
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial of Efruxifermin in Non-Cirrhotic NASH/MASH with Fibrosis
- Phase 3 Randomized Double-Blind Placebo-Controlled Trial of Efruxifermin in Compensated Cirrhosis Due to NASH/MASH
- Evaluation of Tobevibart and Elebsiran Efficacy and Safety in Chronic Hepatitis D Virus Infection Unresponsive to Bulevirtide Therapy
Data & Insights
Has run more than one trial at 60 of 122 partner sites.
Specializations
Hepatic Disorders
The investigator specializes in treating complex liver conditions, with particular emphasis on Non-Alcoholic Steatohepatitis (NASH) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). Their research encompasses both non-cirrhotic and cirrhotic manifestations of these conditions.
- Steatohepatitis Management
- Liver Fibrosis Treatment
- Compensated Cirrhosis Care
The investigator focuses on innovative therapeutic approaches for progressive liver diseases and their complications.
Metabolic Health
Their expertise extends to the metabolic aspects of liver disease, particularly focusing on metabolic dysfunction and its hepatic manifestations. The investigator examines the relationship between metabolic health and liver disease progression.
- Metabolic Disease Management
- Liver Disease Prevention
- Disease Progression Monitoring
The research encompasses comprehensive approaches to metabolic liver disease treatment and outcome improvement.
Clinical Outcomes
The investigator's work centers on evaluating therapeutic efficacy in liver-related clinical outcomes and mortality reduction. Their research includes assessment of disease resolution and fibrosis regression in liver conditions.
- Mortality Risk Assessment
- Disease Resolution Monitoring
- Long-term Outcome Evaluation
The focus includes comprehensive evaluation of treatment responses and clinical endpoints in liver disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.